Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Thymus-specific chemokine protein disclosed by HGS

March 16, 1998

Genzyme General: Q4 1997 highlights

March 16, 1998

Patient enrollment complete for MS-325 phase II trial

March 13, 1998

Method of diagnosing Hodgkin's disease disclosed by cancer research institute

March 13, 1998

Advanced Magnetics in-licenses contrast agent from Andaris

March 10, 1998

Matritech: Q4 and year-end 1997 highlights

March 6, 1998

Cytogen: Q4 and year-end 1997 highlights

March 4, 1998

FDA requests additional information for EchoGen NDA review

March 2, 1998

UroGenesys licenses prostate cancer gene for diagnostic and therapeutic development

Feb. 27, 1998

Thyrogen will receive priority review by the FDA; EU application also accepted

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...